Brentuximab Vedotin with Chemotherapy for Stage 3/4 Classical Hodgkin Lymphoma (cHL): 4-Year Update of the Echelon-1 Study Bartlett, N. L., Straus, D. J., Dlugosz-Danecka, M., Alekseev, S., Illes, A., Lech-Maranda, E., Feldman, T. A., Smolewski, P., Savage, K. J., Walewski, J., Ramchandren, R., Zinzani, P., Hutchings, M., Connors, J. M., Radford, J., Munoz, J., Kim, W., Advani, R. H., Ansell, S. M., Younes, A., Gallamini, A., Miao, H., Liu, R., Fenton, K., Forero-Torres, A., Picardi, M. AMER SOC HEMATOLOGY. 2019

View details for DOI 10.1182/blood-2019-124116

View details for Web of Science ID 000577164602049